Hanumant Gambhire, et al. “AN OVERVIEW OF US FDA WARNING LETTERS TO INDIAN PHARMACEUTICAL INDUSTRIES FOR CGMP VIOLATIONS PERTAINING TO STERILE PRODUCTS”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 29, no. 03, Aug. 2022, pp. 1845-63, https://doi.org/10.53555/jptcp.v29i03.7242.